Will Thomas: Why Dose Every Missed Thromboprophylaxis Matter
Will Thomas, Consultant haematologist at Cambridge University Hospitals NHS Foundation Trust, shared on LinkedIn about a recent article by Scott G. Louis et al, published in JAMA Surgery, adding:
“Experts are often asked to give an opinion on causation when there had been missed prophylactic low-molecular weight heparin doses and hospital acquired thrombosis.
One of the few things we can do is to avoid missed doses. This was identified by a previous GIRFT survey in 2021.
Every case is unique and requires meticulous attention to the circumstances and particular details of the case.
This paper gives valuable data in this area.
Which is helpful for experts albeit data remains limited.”
Title: Correlation of Missed Doses of Enoxaparin With Increased Incidence of Deep Vein Thrombosis in Trauma and General Surgery Patients
Authors: Scott G. Louis, Misa Sato, Travis Geraci, Ross Anderson, S. David Cho, Philbert Y. Van, Jeffrey S. Barton, Gordon M. Riha, Samantha Underwood, Jerome Differding, Jennifer M. Watters, Martin A. Schreiber

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments